Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc

11 Nov 2015 15:06

RNS Number : 3932F
Northern Trust Corporation
11 November 2015
Β 

ο»Ώ

Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Northern Trust Group

Company dealt in

Pfizer Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

10th November 2015

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS*

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

86,715,600 1.40

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

87,715,600 1.40

Β 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 358,250 securities out of the relevant accounts

Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Total

Β 

Β 

3. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (USD)

Buy

60

33.66

Buy

400

33.79

Sell

24372

33.79

Sell

67

33.84

Buy

68

33.66

Buy

7300

33.72

Buy

1500

33.80

Sell

50

33.65

Sell

100

33.67

Sell

10

33.68

Sell

89600

33.69

Sell

25

33.74

Sell

25

33.83

Sell

100

33.87

Buy

477

33.89

Buy

377

33.92

Sell

82

33.63

Sell

948

33.75

Sell

2

33.80

Sell

918

33.81

Sell

75

33.83

Sell

98

33.85

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

4. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ 

relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β 

this shouldΒ beΒ stated.

Β 

Β 

Β 

N/A

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β NO

Β 

Date of disclosure

Β 11th November 2015

Contact name

Paul Adair

Telephone number

020 7982 1236

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBBBATMBMBBTA
Date   Source Headline
19th May 201412:59 pmRNSForm 8.3 - AstraZeneca Plc
19th May 201412:53 pmRNSForm 8.3 - Pfizer Inc
19th May 201412:50 pmRNSForm 8.3 - Pfizer Inc
19th May 201412:24 pmRNSForm 8.5 (EPT/NON-RI) Replacement
19th May 201412:19 pmRNSForm 8.5 (EPT/RI)
19th May 201412:04 pmRNSForm 8.3 - Pfizer Inc
19th May 201411:32 amRNSForm 8.5 (EPT/NON-RI)
19th May 201411:19 amRNSForm 8.5 (EPT/RI)
19th May 201411:18 amRNSForm 8 (DD) - [Pfizer Inc]
19th May 201411:16 amBUSForm 8.3 - Pfizer Inc
19th May 201411:12 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201411:10 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201411:09 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201410:50 amRNSForm 8.5 (EPT/RI) - Pfizer
19th May 20149:22 amRNSRule 2.10 Announcement
19th May 20147:08 amRNSASTRAZENECA BOARD REJECTS PFIZER'S FINAL PROPOSAL
19th May 20147:00 amRNSPFIZER MAKES FINAL PROPOSAL TO ASTRAZENECA
19th May 20147:00 amPRNForm 8.3 - Pfizer Inc.
16th May 20145:00 pmRNSForm 8.3 - Replacement Pfizer Inc
16th May 20144:59 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
16th May 20144:57 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
16th May 20144:33 pmRNSForm 8 (DD) - Pfizer Inc.
16th May 20144:27 pmRNSForm 8.5 (EPT/NON-RI)Amendment
16th May 20144:19 pmRNSForm 8.5 (EPT/NON-RI)
16th May 20143:39 pmRNSForm 8 (DD) - [Pfizer Inc]
16th May 20143:39 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
16th May 20143:34 pmRNSForm 8.3 - Pfizer Inc
16th May 20143:12 pmBUSForm 8.3 - Pfizer Inc
16th May 20143:03 pmRNSForm 8.3 - Pfizer Inc.
16th May 20142:57 pmRNSForm 8.3 - [PFIZER INC]
16th May 20142:39 pmRNSForm 8.3 - Pfizer Inc
16th May 20142:39 pmRNSForm 8.3 - Pfizer Inc.
16th May 20142:38 pmBUSForm 8.3 - Pfizer Inc.
16th May 20142:33 pmBUSForm 8.3 - Pfizer Inc
16th May 20142:32 pmRNSForm 8.3 - [AstraZeneca Plc]
16th May 20142:31 pmRNSForm 8.3 - [Pfizer Inc]
16th May 20141:53 pmBUSForm 8.3 - Pfizer Inc.
16th May 20141:34 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:57 pmBUSForm 8.3 - Pfizer Inc
16th May 201412:33 pmRNSForm 8.3 - [Pfizer Inc]
16th May 201412:32 pmRNSForm 8.5 (EPT/RI)AMENDMENTS
16th May 201412:27 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:26 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:24 pmRNSForm 8.3 - AstraZeneca Plc
16th May 201412:24 pmRNSForm 8.3 - AstraZeneca Plc
16th May 201412:01 pmRNSForm 8.3 - [Pfizer/Astrazeneca]
16th May 201411:55 amRNSForm 8.3 - Pfizer Inc
16th May 201411:54 amRNSForm 8.5 (EPT/RI) - Pfizer Inc.
16th May 201411:40 amRNSForm 8.5 (EPT/RI) Pfizer Inc
16th May 201411:34 amRNSForm 8.5 (EPT/RI) Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.